https://www.elsevier.es/es-revista-medicina-clinica-2-articulo-impact-belimumab-on-glucocorticoid-intake-S0025775324006559
Background and objectivesSystemic lupus erythematosus (SLE) is an autoimmune disease with
newly diagnosedimpactbelimumabglucocorticoidintake
https://www.pharmaceutical-technology.com/data-insights/belimumab-gsk-cryoglobulinemia-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-282561&utm_campaign=recommended-articles-pi
Belimumab is under clinical development by GSK and currently in Phase II for Cryoglobulinemia.
belimumabgskcryoglobulinemialikelihoodapproval